These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13874157)

  • 1. [Results of the treatment of headache with Deseril].
    BRZECKI A
    Pol Tyg Lek; 1962 Mar; 17():440-2. PubMed ID: 13874157
    [No Abstract]   [Full Text] [Related]  

  • 2. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
    ROOKE ED; RUSHTON JG; PETERS GA
    Proc Staff Meet Mayo Clin; 1962 Aug; 37():433-43. PubMed ID: 14493709
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    FRIEDMAN AP
    Angiology; 1960 Aug; 11():364-6. PubMed ID: 13825096
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis of frequent vascular headache with methysergide.
    HALE AR; REED AF
    Am J Med Sci; 1962 Jan; 243():92-8. PubMed ID: 13903795
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoid syndrome: alleviation of diarrhoea and flushing with "Deseril" and Ro 5-1025.
    DUBACH UC; GSELL OR
    Br Med J; 1962 May; 1(5289):1390-1. PubMed ID: 13888007
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1961; 86():95-8. PubMed ID: 13883198
    [No Abstract]   [Full Text] [Related]  

  • 7. [Urinary determination of serotonin in allergic patients. Clinical and biological effects of an antagonist, UML 491 (Deseril Sandoz)].
    GIRARD JP
    Helv Med Acta; 1961 Sep; 28():476-81. PubMed ID: 13898854
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    DALESSIO DJ; CAMP WA; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Mar; 4():235-40. PubMed ID: 13719415
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on headache. The responses of the bulbar conjunctival blood vessels during induced oliguria and diuresis, and their modification by UML-491.
    DALESSIO DJ; CHAPMAN LF; ZILELI T; CATTELL M; EHRLICH R; FORTUIN F; GOODELL H; WOLFF HG
    Arch Neurol; 1961 Dec; 5():590-3. PubMed ID: 13883199
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical observations on LSD-25 and Deseril.
    DOEPFNER W
    Experientia; 1962 Jun; 18():256-7. PubMed ID: 13886913
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of autistic schizophrenic children with LSD-25 and UML-491.
    BENDER L; GOLDSCHMIDT L; SANKAR DV
    Recent Adv Biol Psychiatry; 1961; 4():170-9. PubMed ID: 13867084
    [No Abstract]   [Full Text] [Related]  

  • 14. CENTRAL MECHANISMS IN HEADACHE.
    DALESSIO DJ
    Headache; 1965 Jan; 5():276-8. PubMed ID: 14264176
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new antiserotonin agent in the treatment of asthma, headache, urticaria, severe colitis and rheumatic diseases].
    HERRAIZ BALLESTERO L; SIMKIN ZMUD B
    Prensa Med Argent; 1961 Jan; 48():89-93. PubMed ID: 13713709
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of a serotonin antagonist (UML 491) in carcinoid disease.
    PEART WS; ROBERTSON JI
    Lancet; 1961 Nov; 2(7213):1172-4. PubMed ID: 14484792
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARATIVE STUDY OF ANTISEROTONIN EFFECTS OF LYSENYL AND DESERIL.
    RYSANEK K; VITEK V
    Gastroenterologia; 1964; 102():1-10. PubMed ID: 14187206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.